VivoSeq
Other

Small Bowel Obstruction

0

Pipeline Programs↗

1

Active Trials↗

0

Companies Involved↗

Small Bowel Obstruction is an early-stage landscape with 0 programs across 0 companies.

Intelligence

Pipeline Metrics

Competitive Density

6/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

75/100

Attrition Rate

14/100

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

7

clinical trials

Completed3 · 43%
Unknown status2 · 29%
Enrolling by invitation1 · 14%
Terminated1 · 14%

Clinical Trials

Trial Activity

7 trials

A Study of Intravenous Acetaminophen for Small Bowel Obstruction
Enrolling by invitation·MMayo Clinic·Phase 4·NCT05878015·18 enrolled
(Gastrografin Use in Small Bowel Obstruction Caused by Adherences)
Completed·UUniversity of Bologna·Phase 4·NCT00601809·76 enrolled
Value of CT-Scan and Oral Gastrografin in the Management of Post Operative Small Bowel Obstruction
Completed·UUniversity Hospital, Rouen·Phase 4·NCT00389116·242 enrolled
Identifying the Effect of Somatostatin Treatment in Early Postoperative Simple Small Bowel Obstruction
Completed·NNanjing PLA General Hospital·Phase 4·NCT01082627·44 enrolled
Gastrografin for Treating Small Bowel Obstruction in Children
Terminated·LLondon Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's·Phase 2/3·NCT03573921·2 enrolled
Does Icodextrin Reduce the Risk of Small Bowel Obstruction?
Unknown status·UUppsala University·N/A·NCT02318888·1,808 enrolled
The Use of Gastrografin in Chronic Radiation Enteropathy With Small Bowel Obstruction
Unknown status·JJinling Hospital, China·N/A·NCT03642288·112 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)